Xenon制药(XENE)

37.49 0.40 1.0785%

今开:37.4昨收:37.09
最高:37.9485 最低:36.84
涨停价:0.0跌停价:0.0
总市值:2.829328424E9

Xenon制药的热门讨论

其他

Xenon制药(XENE)04-27 04:35

$Xenon制药(XENE)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-049201  Act: 34  Size: 1 MB 网页链接查看全文

当期报告

Xenon制药(XENE)06-06 04:15

$Xenon制药(XENE)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0000950170-24-069318  Act: 34  Size: 629 KB 网页链接查看全文

员工持股计划

Xenon制药(XENE)06-06 04:25

$Xenon制药(XENE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-069340  Act: 33  Size: 230 KB 网页链接查看全文

当期报告

Xenon制药(XENE)05-10 04:15

$Xenon制药(XENE)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0000950170-24-056940  Act: 34  Size: 308 KB 网页链接查看全文

证券出售报告

Xenon制药(XENE)06-06 05:35

$Xenon制药(XENE)$ 144 Report of proposed sale of securities Accession Number: 0000950170-24-069439  Act: 33  Size: 6 KB 网页链接查看全文

当期报告

Xenon制药(XENE)04-20 04:25

$Xenon制药(XENE)$ 8-K Current report, item 5.02 Accession Number: 0000950170-24-046023  Act: 34  Size: 162 KB 网页链接查看全文

股东委托书协议

Xenon制药(XENE)04-27 04:35

$Xenon制药(XENE)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-049198  Act: 34  Size: 4 MB 网页链接查看全文

持股变动声明

Xenon制药(XENE)06-06 05:45

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069466  Size: 14 KB 网页链接查看全文

持股变动声明

Xenon制药(XENE)06-06 05:45

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069465  Size: 5 KB 网页链接查看全文

持股变动声明

Xenon制药(XENE)06-06 05:45

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069464  Size: 5 KB 网页链接查看全文

1 2

Xenon制药的最新讨论

淘沙见金2018-07-02 10:47

$Xenon Pharmaceuticals Inc. (XENE)$ It has two epilepsy programs, XEN1101and XEN901. Though they are still in phase 1, at the current levels the upside potential is too significant to ignore.查看全文

usbiostock2018-05-15 23:21

$Xenon Pharmaceuticals Inc.(XENE)$ 公司公布XEN1101临床1期试验中期阳性结果。查看全文

WitnessBio2018-05-15 20:57

$Xenon Pharmaceuticals Inc. (XENE)$ 可惜这个错过了查看全文

Takeabreak2017-11-13 11:16

$Xenon Pharmaceuticals Inc.(XENE)$ what happened? $2.45 Nov 10查看全文

薛定锷之猫2017-03-23 04:00

$Xenon Pharmaceuticals(XENE)$ capital world+capital research 共2.4m股,EU批了查看全文

wfan20222015-07-01 21:54

$Xenon Pharmaceuticals(XENE)$ Thinly traded micro cap Xenon Pharmaceuticals (NASDAQ:XENE) drops 22% premarket on increased volume in response to its announcement that a Phase 2b trial run by development partner Teva Pharmaceutical Industries (NYSE:TEVA) evaluating TV-45070 (f...查看全文

UUUSHI2015-06-30 23:14

$Xenon Pharmaceuticals(XENE)$ 这货怎么这么弱[怒了][怒了]查看全文

浩南哥2015-06-17 21:33

$Xenon Pharmaceuticals(XENE)$ 突破了.[跪了]查看全文

1 2 3 4

Xenon制药的新闻

美股异动 | Xenon Pharmaceuticals(XENE.US)涨逾74%,药物XEN1101临床2b期试验结果积极

智通财经APP获悉,10月4日(周一)美股盘初,截至北京时间22:02,专注于神经学的生物制药公司Xenon Pharmaceuticals(XENE.US)涨74.78%,报27.265美元。早前,该公司公布了2b期X-Tole临床试验的积极结果,该临床试验评估了XEN1101的临床有... 网页链接

Xenon制药的公告

证券出售报告

$Xenon制药(XENE)$ 144 Report of proposed sale of securities Accession Number: 0000950170-24-072572  Act: 33  Size: 5 KB 网页链接

持股变动声明

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069465  Size: 5 KB 网页链接

持股变动声明

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069464  Size: 5 KB 网页链接

持股变动声明

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069462  Size: 14 KB 网页链接

持股变动声明

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069463  Size: 14 KB 网页链接

持股变动声明

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069466  Size: 14 KB 网页链接

持股变动声明

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069468  Size: 14 KB 网页链接

持股变动声明

$Xenon制药(XENE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069467  Size: 14 KB 网页链接

证券出售报告

$Xenon制药(XENE)$ 144 Report of proposed sale of securities Accession Number: 0000950170-24-069439  Act: 33  Size: 6 KB 网页链接

员工持股计划

$Xenon制药(XENE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-069340  Act: 33  Size: 230 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54